GABRIELL VIELE: Open Payments
NPI 1528675246 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 42 payments from 15 companies in 2025. Trend: 2023 $1,583 · 2024 $633 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $264 |
| Biogen, Inc. | 1 | $96 |
| SK Life Science, Inc. | 3 | $72 |
| Eisai Inc. | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $62 |
| UCB, Inc. | 2 | $59 |
| Lilly USA, LLC | 3 | $58 |
| PFIZER INC. | 3 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Neurelis, Inc. | 1 | $45 |
Products named: QULIPTA, TYSABRI, UBRELVY, Leqembi, INGREZZA, Rystiggo, KISUNLA, Dysport.
Industry payments across NY — which companies pay providers there.
